DANVERS, Mass.--(BUSINESS WIRE)--The United States Food and Drug Administration (FDA) has granted 510(k) clearance to Abiomed (Nasdaq: ABMD) for its Impella Low Profile Sheath. Compared to the ...
At Abiomed's European headquarters in Aachen, Germany, Impella heart pumps have been developed and produced for more than 20 years to stabilize and recover the human heart. The single access procedure ...
The US Food and Drug Administration has granted 510(k) clearance for Abiomed's Impella Low Profile Sheath used to place and manage Impella heart pumps. "The Low Profile Sheath is the first sheath ...
Mon, October 17, 2022 at 3:35 PM UTC Don't miss real-time alerts on your stocks - join Benzinga Pro for free! Try the tool that will help you invest smarter, faster, and better.
WASHINGTON, D.C.—Johnson & Johnson MedTech’s Abiomed announced that its compressible, expandable heart pump has cleared a pivotal trial, and it’s now headed for FDA review in the coming months. The ...
The Impella XR sheath is a low-profile sheath that expands and recoils, allowing for small bore access and closure with the Impella 2.5 heart pump. It inserts at 10 French (Fr) and the flexible, ...
Please provide your email address to receive an email when new articles are posted on . Abiomed announced the FDA has granted 510(k) clearance for its low-profile sheath for percutaneous placement of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results